Compare T & TMO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | T | TMO |
|---|---|---|
| Founded | 1983 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Industrial Machinery/Components |
| Sector | Telecommunications | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 186.8B | 216.4B |
| IPO Year | N/A | N/A |
| Metric | T | TMO |
|---|---|---|
| Price | $24.32 | $562.32 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 21 | 19 |
| Target Price | $30.84 | ★ $631.00 |
| AVG Volume (30 Days) | ★ 37.8M | 1.6M |
| Earning Date | 01-28-2026 | 01-29-2026 |
| Dividend Yield | ★ 4.56% | 0.31% |
| EPS Growth | ★ 150.83 | 8.54 |
| EPS | 3.08 | ★ 17.32 |
| Revenue | ★ $124,480,000,000.00 | $43,736,000,000.00 |
| Revenue This Year | $4.18 | $4.33 |
| Revenue Next Year | $1.45 | $4.94 |
| P/E Ratio | ★ $7.91 | $32.49 |
| Revenue Growth | 1.98 | ★ 3.22 |
| 52 Week Low | $21.38 | $385.46 |
| 52 Week High | $29.79 | $610.97 |
| Indicator | T | TMO |
|---|---|---|
| Relative Strength Index (RSI) | 37.88 | 43.49 |
| Support Level | $24.01 | $561.00 |
| Resistance Level | $24.81 | $579.08 |
| Average True Range (ATR) | 0.44 | 11.41 |
| MACD | -0.08 | -2.91 |
| Stochastic Oscillator | 15.56 | 17.31 |
The wireless business contributes nearly 70% of AT&T's revenue. The company is the third-largest US wireless carrier, connecting 73 million postpaid and 17 million prepaid phone customers. Fixed-line enterprise services, which account for about 14% of revenue, include internet access, private networking, security, voice, and wholesale network capacity. Residential fixed-line services, about 12% of revenue, primarily consist of broadband internet access, serving 14 million customers. AT&T also has a sizable presence in Mexico, with 24 million customers, but this business only accounts for 3% of revenue. The company recently sold its 70% equity stake in satellite television provider DirecTV to its partner, private equity firm TPG.
Thermo Fisher Scientific sells scientific instruments and laboratory equipment, diagnostics consumables, and life science reagents. The firm operates through four segments as of year-end 2024 (revenue figures include some cross-segment revenue): analytical technologies (17% of sales); specialty diagnostic products (11%); life science solutions (23%); and lab products and services, which includes CRO services (the remainder).